NICE has given Bayer’s advanced liver cancer therapy Stivarga (regorafenib) the go-ahead after it undertook a rapid review following earlier guidance that rejected the drug.
The nominations for the new face to grace the plastic £50 note have been revealed and woman scientist Rosalind Franklin, backed by the UK's pharma body, is among the frontrunners.<
